title: New Treatment Guidelines for Sjögren's Disease.
abstract: Sjögren's disease is associated with a high burden of illness, diminished quality of life, and increased health care costs. The Sjögren's Syndrome Foundation developed the first US clinical practice guidelines for management of the oral, ocular, and rheumatologic or systemic manifestations. Guideline recommendations were reviewed by a consensus expert panel using a modified Delphi process. This initiative should improve the quality and consistency of care for Sjögren's disease in the United States, guide insurance reimbursement, and define areas for future study. Guidelines will be periodically reviewed and revised as new information becomes available.
authors.affiliation: Division of Rheumatology, Penn Presbyterian Medical Center, Penn Sjögren's Center, Penn Medicine University City, University of Pennsylvania, 3737 Market Street, Philadelphia, PA 19104, USA. Electronic address: frederick.vivino@uphs.upenn.edu.
authors.forename: Frederick B
authors.initials: FB
authors.lastname: Vivino
authors.affiliation: Division of Rheumatology, Allergy and Immunology, Winthrop University Hospital, 120 Mineola Boulevard, Suite 410, Mineola, NY 11501, USA; Stony Brook University School of Medicine, Stony Brook, 120 Mineola Boulevard, Mineola, NY 11501, USA.
authors.forename: Steven E
authors.initials: SE
authors.lastname: Carsons
authors.affiliation: Department of Ophthalmology and Vision Science, University of Louisville School of Medicine, 301 East Muhammad Ali Boulevard, Louisville, KY 40202, USA.
authors.forename: Gary
authors.initials: G
authors.lastname: Foulks
authors.affiliation: Department of Orofacial Sciences, UCSF Schools of Dentistry and Medicine, 521 Parnassus Avenue, Clinic Sci, San Francisco, CA 94143, USA.
authors.forename: Troy E
authors.initials: TE
authors.lastname: Daniels
authors.affiliation: Division of Rheumatology, St. Francis Hospital & Medical Center, 114 Woodland Street, Hartford, CT 06105, USA.
authors.forename: Ann
authors.initials: A
authors.lastname: Parke
authors.affiliation: Department of Oral Medicine, Carolinas Medical Center, 1000 Blythe Boulevard, Charlotte, NC 28203, USA.
authors.forename: Michael T
authors.initials: MT
authors.lastname: Brennan
authors.affiliation: Corneal Consultants of Colorado, 8381 Southpark Lane, Littleton, CO 80120, USA.
authors.forename: S Lance
authors.initials: SL
authors.lastname: Forstot
authors.affiliation: Department of Veterans Affairs, Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, 1000 North Lincoln Boulevard, #2900, Oklahoma City, OK 73104, USA.
authors.forename: R Hal
authors.initials: RH
authors.lastname: Scofield
authors.affiliation: Sjögren's Syndrome Foundation, 6707 Democracy Boulevard, Suite 325, Bethesda, MD 20817, USA.
authors.forename: Katherine M
authors.initials: KM
authors.lastname: Hammitt
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use*; D002327:Cariostatic Agents / Q000627:therapeutic use; D017281:Cost of Illness; D003697:Delphi Technique; D003731:Dental Caries / Q000209:etiology / Q000517:prevention & control; D005081:Exercise Therapy; D005221:Fatigue / Q000209:etiology / Q000628:therapy; D005459:Fluorides / Q000627:therapeutic use; D017048:Health Care Costs; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D000069283:Rituximab / Q000627:therapeutic use; D012648:Self Care; D012720:Severity of Illness Index; D012859:Sjogren's Syndrome / Q000188:drug therapy*
chemical_list: D018501:Antirheumatic Agents; D001688:Biological Products; D002327:Cariostatic Agents; D000069283:Rituximab; D006886:Hydroxychloroquine; D005459:Fluorides
keywords: Arthritis; Biologics; Caries; DMARDS; Dry eye; Fatigue; Sjögren's; Treatment